The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2020
Filed:
Apr. 07, 2016
Applicant:
Guangdong Raynovent Biotech Co., Ltd., Guangdong, CN;
Inventors:
Chaofeng Long, Dongguan, CN;
Zhengxia Chen, Dongguan, CN;
Xiaoxin Chen, Dongguan, CN;
Yang Zhang, Dongguan, CN;
Zhuowei Liu, Dongguan, CN;
Peng Li, Dongguan, CN;
Shuhui Chen, Dongguan, CN;
Guibai Liang, Dongguan, CN;
Cheng Xie, Dongguan, CN;
Zhengwei Li, Dongguan, CN;
Zhifei Fu, Dongguan, CN;
Guoping Hu, Dongguan, CN;
Jian Li, Dongguan, CN;
Assignee:
GUANGDONG RAYNOVENT BIOTECH CO., LTD., Guangdong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 215/48 (2006.01); C07D 405/14 (2006.01); C07F 9/60 (2006.01); C07D 401/12 (2006.01); C07D 417/12 (2006.01); C07D 498/04 (2006.01); C07D 491/056 (2006.01); A61K 31/4709 (2006.01); A61K 31/53 (2006.01); A61P 35/00 (2006.01); C07D 401/10 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 417/10 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 215/48 (2013.01); A61K 31/4709 (2013.01); A61K 31/53 (2013.01); A61P 35/00 (2018.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 417/10 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/056 (2013.01); C07D 498/04 (2013.01); C07F 9/60 (2013.01);
Abstract
The present invention relates to a tyrosine kinase inhibitor and a pharmaceutical composition comprising same. The tyrosine kinase inhibitor of the present invention has the structures as shown in the following formula (I) or (II):